tooluniverse-clinical-trial-design
Warn
Audited by Snyk on Mar 29, 2026
Risk Level: MEDIUM
Full Analysis
MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).
- Third-party content exposure detected (high risk: 1.00). The skill's mandatory workflow (SKILL.md "Tool Reference by Research Path" and STUDY_DESIGN_PROCEDURES.md / WORKFLOW_DETAILS.md) requires calling and ingesting open/public third‑party sources such as PubMed_search_articles, search_clinical_trials (ClinicalTrials.gov), OpenTargets, ClinVar/COSMIC/gnomAD, FAERS, DrugBank and OpenFDA, and the agent must read and synthesize those untrusted, user‑generated/public data to drive feasibility scores and design decisions—so external content can materially influence actions.
Issues (1)
W011
MEDIUMThird-party content exposure detected (indirect prompt injection risk).
Audit Metadata